1. Home
  2. HLVX vs SOL Comparison

HLVX vs SOL Comparison

Compare HLVX & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLVX
  • SOL
  • Stock Information
  • Founded
  • HLVX 2020
  • SOL 2005
  • Country
  • HLVX United States
  • SOL United States
  • Employees
  • HLVX N/A
  • SOL N/A
  • Industry
  • HLVX Biotechnology: Pharmaceutical Preparations
  • SOL Semiconductors
  • Sector
  • HLVX Health Care
  • SOL Technology
  • Exchange
  • HLVX Nasdaq
  • SOL Nasdaq
  • Market Cap
  • HLVX 104.3M
  • SOL 98.5M
  • IPO Year
  • HLVX 2022
  • SOL 2008
  • Fundamental
  • Price
  • HLVX $2.09
  • SOL $1.89
  • Analyst Decision
  • HLVX Hold
  • SOL Strong Buy
  • Analyst Count
  • HLVX 1
  • SOL 2
  • Target Price
  • HLVX $2.00
  • SOL $4.50
  • AVG Volume (30 Days)
  • HLVX 862.9K
  • SOL 119.1K
  • Earning Date
  • HLVX 11-06-2025
  • SOL 11-13-2025
  • Dividend Yield
  • HLVX N/A
  • SOL N/A
  • EPS Growth
  • HLVX N/A
  • SOL N/A
  • EPS
  • HLVX N/A
  • SOL N/A
  • Revenue
  • HLVX N/A
  • SOL $68,445,000.00
  • Revenue This Year
  • HLVX N/A
  • SOL N/A
  • Revenue Next Year
  • HLVX N/A
  • SOL $45.37
  • P/E Ratio
  • HLVX N/A
  • SOL N/A
  • Revenue Growth
  • HLVX N/A
  • SOL N/A
  • 52 Week Low
  • HLVX $1.34
  • SOL $1.04
  • 52 Week High
  • HLVX $2.17
  • SOL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • HLVX 51.29
  • SOL 54.27
  • Support Level
  • HLVX $2.07
  • SOL $1.87
  • Resistance Level
  • HLVX $2.11
  • SOL $1.91
  • Average True Range (ATR)
  • HLVX 0.02
  • SOL 0.03
  • MACD
  • HLVX -0.00
  • SOL 0.00
  • Stochastic Oscillator
  • HLVX 50.00
  • SOL 81.00

About HLVX HilleVax Inc.

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.

Share on Social Networks: